NasdaqGS - Delayed Quote USD
Guardant Health, Inc. (GH)
At close: November 15 at 4:00 PM EST
After hours: November 15 at 7:47 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-254,073.00
-324,975.00
-309,463.00
-209,017.00
-103,927.00
Investing Cash Flow
391,616.00
840,250.00
149,816.00
-63,155.00
-617,086.00
Financing Cash Flow
92,507.00
477,375.00
-189,093.00
-66,824.00
1,410,307.00
End Cash Position
687,413.00
1,133,687.00
141,948.00
492,288.00
832,977.00
Income Tax Paid Supplemental Data
--
1,969.00
1,331.00
393.00
331.00
Capital Expenditure
-20,287.00
-20,486.00
-77,461.00
-75,035.00
-54,059.00
Issuance of Capital Stock
90,616.00
493,116.00
--
--
355,730.00
Issuance of Debt
--
--
--
--
1,132,750.00
Repayment of Debt
--
--
-71.00
-146.00
-174.00
Repurchase of Capital Stock
-723.00
--
--
--
--
Free Cash Flow
-274,360.00
-345,461.00
-386,924.00
-284,052.00
-157,986.00
12/31/2020 - 10/4/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
EXAS Exact Sciences Corporation
49.33
-3.14%
NTRA Natera, Inc.
146.06
-3.34%
TWST Twist Bioscience Corporation
36.89
-5.31%
ILMN Illumina, Inc.
135.05
-5.05%
GRAL GRAIL, Inc.
14.80
-6.39%
VCYT Veracyte, Inc.
35.94
-2.97%
RDNT RadNet, Inc.
79.58
-1.83%
CDNA CareDx, Inc
21.17
-1.76%
MYGN Myriad Genetics, Inc.
15.25
-2.74%
NEO NeoGenomics, Inc.
15.04
-4.75%